These leaders will identify and advance high-potential assets from preclinical through Phase 1 clinical stages, shape early partnering strategies, and drive transactions in collaboration with Business Development
Job Summary
These leaders will identify and advance high-potential assets from preclinical through Phase 1 clinical stages, shape early partnering strategies, and drive transactions in collaboration with Business Development.
Serve as the senior Early S&E leader within the TALT, influencing therapeutic strategy and ensuring external innovation priorities are integrated into portfolio planning.
CSL Behring is a global biotherapeutics leader driven by our promise to save lives, focused on serving patients’ needs by using the latest technologies.
Matching Summary
These leaders will identify and advance high-potential assets from preclinical through Phase 1 clinical stages, shape early partnering strategies, and drive transactions in collaboration with Business Development.
Skills & Requirements
Must-have
External innovation sourcing and evaluation
Hematology or Cardiovascular/Renal expertise
Preclinical through Phase 1 asset identification
Early partnering strategy development
Cross-functional due diligence leadership
Biotech and academic community engagement
Nice-to-have
Influencing therapeutic strategy
Cultivating external relationships
Driving transactions and deal closure
Key Requirements
Advanced degree (PhD, MD, or equivalent)
Significant biopharma experience
Experience in external innovation, S&E, or BD
Proven track record of leading due diligence
Proven track record of closing early-stage deals
Strong network within biotech, academia, pharma BD